Co-Diagnostics Announces New Vector Control Orders and Continued Progress Toward Regulatory Clearance for Coronavirus Test
Co-Diagnostics, Inc. (CODX)
US:NASDAQ Investor Relations:
ir.codiagnostics.com/investor-relations
Company Research
Source: Business Wire
SALT LAKE CITY--(BUSINESS WIRE)--Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests, announced today that it has received new orders for its vector control tests and equipment from mosquito abatement districts following attendance at several vector control conferences. Recent conference appearances included a presentation at the 3rd International Conference on Zika Virus and Aedes Related Infections on February 13-16, 2020, in Washington, D.C., where Co-Diagnostics was well-received by the global audience.The conference provided a forum for the Company to showcase its technology platform and full suite of mosquito abatement tests to those in attendance, and to report on its rapid response to the outbreak of COVID-19 during the conference’s coronavirus symposia.Co-Diagnostics has recently added new mosquito abatement customers in the Eastern United States as well as the Midwest. Significantly
Show less
Read more
Impact Snapshot
Event Time:
CODX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CODX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CODX alerts
High impacting Co-Diagnostics, Inc. news events
Weekly update
A roundup of the hottest topics
CODX
News
- Co-Diagnostics, Inc. CEO Delivers Manufacturing and Commercialization Update in Conference Keynote Address [Yahoo! Finance]Yahoo! Finance
- Co-Diagnostics, Inc. CEO Delivers Manufacturing and Commercialization Update in Conference Keynote AddressPR Newswire
- Global Covid-19 Diagnostic Market Analysis Report 2024: A New Large and Sustainable Market for Covid Related Diagnostics is Emerging [Yahoo! Finance]Yahoo! Finance
- Co-Diagnostics, Inc. CEO to Deliver Keynote Address at MarketsandMarkets 2024 in London, England [Yahoo! Finance]Yahoo! Finance
- Co-Diagnostics, Inc. CEO to Deliver Keynote Address at MarketsandMarkets 2024 in London, EnglandPR Newswire
CODX
Earnings
- 11/9/23 - Beat
CODX
Sec Filings
- 3/20/24 - Form 3
- 3/15/24 - Form 8-K
- 3/14/24 - Form 10-K
- CODX's page on the SEC website